ACTINIUM PHARMACEUTICALS INC (ATNM) Stock Cash Flow
NYSEARCA:ATNM - NYSE Arca - US00507W2061 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -45.51M | -38.24M | -48.82M | -33.02M | -24.77M | |||
| Depreciation Amortization | 800.00K | 811.00K | 790.00K | 699.00K | 524.00K | |||
| Change In Working Capital | -1.35M | -932.00K | -3.15M | 38.17M | 1.69M | |||
| Interest Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Taxes Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other non cash items | 12.79M | 5.29M | 3.84M | 2.79M | 1.69M | |||
| OPERATING CASH FLOW | -33.27M | -33.07M | -47.34M | 8.64M | -20.87M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | 0.00 | -11.00K | -153.00K | -366.00K | -133.00K | |||
| Other Investing Activity | N/A | N/A | N/A | N/A | N/A | |||
| INVESTING CASH FLOW | 0.00 | -11.00K | -153.00K | -366.00K | -133.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -9.00K | -9.00K | -4.00K | -49.00K | -85.00K | |||
| Stock Issued/Repurchased | N/A | 29.33M | 14.87M | 23.16M | 35.31M | |||
| FINANCING CASH FLOW | 14.55M | 29.32M | 14.87M | 23.11M | 35.22M | |||
| CHANGE IN CASH | -18.72M | -3.76M | -32.62M | 31.39M | 14.22M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -33.27M | -33.07M | -47.34M | 8.64M | -20.87M | |||
| Capital Expenditure | 0.00 | -11.00K | -153.00K | -366.00K | -133.00K | |||
| FREE CASH FLOW | -33.27M | -33.08M | -47.49M | 8.28M | -21.00M | |||
All data in USD